|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Trusts (England) - Medical Director
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Director of Public Health
- NHS Trusts (England) - Chief Executive
- GP - Locum
- NHS 111 and Out of hours providers
- Dispensing GP Practices
- DHSC Supply Disruption - Medicines
- Community Pharmacy
- Primary Care Networks
|
| Action category: |
|
Class 2: Action within 48 hours
|
| Title: |
|
CLASS 2 DRUG ALERT, ACTION WITHIN 48 HOURS, AVENTIS PHARMA LIMITED (T/A SANOFI), LARGACTIL 50MG/2ML SOLUTION FOR INJECTION, PL 04425/0582
|
| Broadcast content: |
|
Sanofi is recalling specific batches due to out of specification results obtained for the impurity chlorpromazine sulphoxide, which was suspected to be caused by increased oxidation as a result of higher oxygen content in the headspace of the ampoules. As a precautionary measure, these batches are being recalled.
Advice for healthcare professionals: Stop supplying the above batches immediately. Quarantine all stock and return it to your supplier using your supplier's approved process.
Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-delivery-alerts
|
| Additional information: |
|
NHS England and NHS Improvement Regional Offices: Please cascade this alert to Community Pharmacies
GP Practices: Please note this alert is for Dispensing GP Practices only
|
| Cascade to: |
|
- #COMMUNITYPHARMACISTS#
- #DISPENSING GP#
- #HospitalPharmacy#
|